Rong Mu, n/a

Peking University Third Hospital
Beijing, China (People's Republic)

Presentation(s):

• 0647: anti-cd19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus: An Open-label Pilot Study

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.